| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.33 | 7e-08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.3 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.089 | 0.2 |